Cencora(US:COR) ZACKSยท2025-08-01 14:16Core Insights - Analysts forecast Cencora (COR) will report quarterly earnings of $3.78 per share, reflecting a year-over-year increase of 13.2% and revenues of $80.33 billion, an 8.2% increase compared to the previous year [1] Earnings Estimates - There has been no revision in the consensus EPS estimate for the quarter over the last 30 days, indicating stability in analysts' forecasts [2] - Revisions to earnings projections are crucial for predicting investor behavior and are linked to short-term stock price performance [3] Revenue Projections - Revenue from Total International Healthcare Solutions is projected to reach $7.30 billion, a 3.5% year-over-year increase [5] - Revenue from Total U.S. Healthcare Solutions is estimated at $72.81 billion, indicating an 8.4% increase from the prior-year quarter [5] - Revenue for International Healthcare Solutions- Alliance Healthcare is expected to be $5.77 billion, a 2.3% increase year-over-year [6] - Revenue from U.S. Healthcare Solutions- Animal Health is forecasted at $1.41 billion, reflecting a 3.1% year-over-year increase [6] - Revenue for U.S. Healthcare Solutions- Human Health is likely to reach $70.79 billion, suggesting a 7.6% year-over-year increase [7] - Revenue for International Healthcare Solutions- Other Healthcare Solutions is expected to be $1.51 billion, indicating a 7.1% increase from the previous year [7] Operating Income Estimates - The consensus estimate for Non-GAAP Operating Income from International Healthcare Solutions is $183.01 million, compared to $179.39 million from the previous year [8] - Non-GAAP Operating Income from U.S. Healthcare Solutions is forecasted to be $844.83 million, up from $698.31 million in the same quarter last year [8] Stock Performance - Cencora shares have decreased by 3.4% over the past month, contrasting with a 2.3% increase in the Zacks S&P 500 composite [8] - Cencora holds a Zacks Rank 2 (Buy), indicating expectations of outperforming the overall market in the near future [8]